About Astemax Biotech Private Limited
Data last updated:
Astemax Biotech Private Limited is a private limited company based in Karnal, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 July 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24100HR2011PTC043480. Its GSTIN is 06AALCA4049F1ZS (Haryana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Astellas Biotech Private Limited. It is led by directors Devi Dyal and Rahul Choudhary.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at SCO 15 1st Floor Sector – 8 Main Market, Karnal, Haryana, India – 132001.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.24 Cr, a decline of 13% compared to the previous year. For the same year it recorded a net profit of ₹2.79 Lakh (net margin 0.9%) and EBITDA of ₹4.68 Lakh (EBITDA margin 1.4%). Revenue has declined at a compounded annual rate (CAGR) of 15% over three years and 6% over five years.
Court records list 4 cases involving the company, including 4 filed by the company; 3 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website astemaxbio.com.
Company details
Contact details
Astemax Biotech Private Limited's registered office is in Karnal, Haryana. Its website is astemaxbio.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressSCO 15 1st Floor Sector – 8 Main Market, Karnal, Haryana, India – 132001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Astemax Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Astemax Biotech is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Astemax Biotech Private Limited, buy the company report.
Financials of Astemax Biotech Private Limited
FY 2025 filings availableAstemax Biotech Private Limited reported revenue of ₹3.24 Cr (down 13% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 6% over five years, including a 13% fall in the latest year. EBITDA fell 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.68 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.79 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.4% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Astemax Biotech Private Limited, buy the company report.
Board of directors of Astemax Biotech Private Limited
Astemax Biotech has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Devi Dyal | Director | 01 Apr 2019 | 7 Years 6 Months | Current |
| Rahul Choudhary Also directs: Essendon Formulations Private Limited | Director | 21 Feb 2022 | 4 Years 8 Months | Current |
Peer comparison
Astemax Biotech Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Astemax Biotech Private Limitedthis company | ₹3.24 Cr (FY 2025) | ₹2.79 Lakh | 0.9% | -13.0% | Karnal, Haryana, India | |
| Pharmia Bio Genesis Private Limited | ₹3.23 Cr (FY 2025) | 2.0% | Cholanayayakanahalli, Karnataka, India | |||
| Arkle Healthcare Private Limited | ₹3.23 Cr (FY 2025) | -1.0% | Chandigarh, India | |||
| Pulin Pharmaceuticals Private Limited | ₹3.22 Cr (FY 2025) | 4.0% | Jaipur, Rajasthan, India |
To see the full peer comparison of Astemax Biotech Private Limited, buy the company report.
Auditor
Astemax Biotech Private Limited is audited by K R C & CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K R C & CO | FY 2017 | KRC024827N |
Shareholding
The shareholding of Astemax Biotech Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Astemax Biotech Private Limited, buy the company report.
Legal cases
Astemax Biotech Private Limited has 4 court cases on record: 4 filed by Astemax Biotech. 3 cases are pending and 1 is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 0 | 3 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Karnal, Haryana | Cheque dishonour complaint | Filed by the company against M/S Akshaya Pharmaceuticals and 1 other | Pending |
| District court, Karnal, Haryana | Cheque dishonour complaint | Filed by the company against M/S Vee Bros. Pharma and 1 other | Pending |
| District court, Karnal, Haryana | Cheque dishonour complaint | Filed by the company against M/S Vee Bros. Pharma. and 1 other | Pending |
| District court, Karnal, Haryana | Cheque dishonour complaint | Filed by the company against an individual | Disposed |
To see the full case history of Astemax Biotech Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Astemax Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Astemax Biotech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AALCA4049F1ZS | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Astemax Biotech Private Limited, buy the company report.
Recent activity
Astemax Biotech Private Limited has 7 board changes on record since 2018: 2 appointments and 5 cessations. The latest: Duli Chand ceased to be Director on 24 Feb 2022.
Frequently asked questions
Astemax Biotech is an active private limited company based in Karnal, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 July 2011 (15+ years old) and is registered under CIN U24100HR2011PTC043480.
Astemax Biotech has 2 current directors:
- Devi Dyal - Director
- Rahul Choudhary - Director
The latest financial statements of Astemax Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Astemax Biotech is 06AALCA4049F1ZS, registered in Haryana.
The CIN (Corporate Identification Number) of Astemax Biotech is U24100HR2011PTC043480. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Astemax Biotech has 4 court cases on record: 4 filed by the company. 3 are pending.
Astemax Biotech was incorporated on 25 July 2011, making it 15+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Astemax Biotech by revenue are Pharmia Bio Genesis Private Limited, Arkle Healthcare Private Limited, Pulin Pharmaceuticals Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Duli Chand ceased to be Director on 24 Feb 2022. Rahul Choudhary was appointed as Director on 21 Feb 2022. Devi Dyal was appointed as Director on 01 Apr 2019. Astemax Biotech has 7 board changes on record in total.
Astemax Biotech can be reached through the website astemaxbio.com. Its registered office is in Karnal, Haryana, India.
The registered office of Astemax Biotech is at SCO 15 1st Floor Sector – 8 Main Market, Karnal, Haryana, India – 132001.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
